Zacks Investment Research downgraded Surgery Partners Inc (NASDAQ:SGRY) to Sell in a statement released earlier today.
- Updated: October 15, 2016
Zacks Investment Research has downgraded Surgery Partners Inc (NASDAQ:SGRY) to Sell in a statement released on 10/12/2016.
On 6/10/2016, KeyBanc Capital Markets released a statement on Surgery Partners Inc (NASDAQ:SGRY) upped the target price from $0.00 to $21.00 that suggested an upside of 0.38%.
Having a price of $19.68, Surgery Partners Inc (NASDAQ:SGRY) traded -1.57% lower on the day. With the last close up 19.45% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the same period. Surgery Partners Inc has recorded a 50-day average of $19.48 and a two hundred day average of $16.80. Volume of trade was down over the average, with 61,377 shares of SGRY changing hands under the typical 131,300
See Chart Below
Surgery Partners Inc has a 52 week low of $11.76 and a 52 week high of $22.32 with a P/E ratio of 108.49 The company’s market cap is currently $0.
In addition to Zacks Investment Research reporting its target price, a total of 9 firms have reported on the stock. The average stock price target is $21.89 with 0 brokers rating the stock a strong buy, zero brokerages rating the company a buy, zero equity analysts rating the company a hold, zero firms rating the stock a underperform, and finally 0 brokerages rating the stock a sell.
General Information About Surgery Partners Inc (NASDAQ:SGRY)
Surgery Partners, Inc. is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company's Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services. The Company's Ancillary Services segment consists of a diagnostic laboratory, a specialty pharmacy and multi-specialty physician practices. The Company's physician practices include its owned and operated physician practices pursuant to management service agreements. The Company's optical services segment consists of an optical laboratory, an optical products group purchasing organization and a marketing business. The Company's optical laboratory manufactures eyewear, while its optical product purchasing organization negotiates volume buying discounts with optical product manufacturers.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.